Neuropsychiatric systemic lupus erythematosus is associated with imbalance in interleukin 10 promoter haplotypes

Annals of the Rheumatic Diseases

Volumn 58, Issue 2, 1999, Pages 85-89

  Rood, M J ^a   Keijsers, V ^a   Van Der Linden, M W ^a   Tong, T Q T ^a   Borggreve, S E ^a   Verweij, C L ^a   Breedveld, F C ^a   Huizinga, T W J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENOTYPE; HAPLOTYPE; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; NEUROPSYCHIATRY; PRIORITY JOURNAL; PROMOTER REGION; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0033006098     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.58.2.85     Document Type: Article

References (30)

1. 1 Block SR, Winfield JB, Lockshin MD, D'Angelo WA, Christian CL. Studies of twins with systemic lupus erythematosus. Am J Med 1975;59:533-52.
2. 2 Arnett FC. The genetic basis of lupus erythematosus. In: Wallace DJ, Hahn BH, eds. Dubois' lupus erythematosus. 4th ed. Philadelphia: Lea and Febiger, 1993:13-36.
3. 3 Truedsson L, Sturfelt G, Johansen P, Nived O, Thuresson B. Sharing of MHC haplotypes among patients with systemic lupus erythematosus from unrelated Caucasian multicase families: disease association with the extended haplotype [HLA-B8, SC01, DR17]. J Rheumatol 1995;22:1852-61.
4. 4 Sturfelt G, Hellmer G, Truedsson L. TNF microsatellites in systemic lupus erythematosus-a high frequency of the TNFabc 2-3-1 haplotype in multicase SLE families. Lupus 1996;5:618-22.
5. 5 Sullivan KE, Wotten C, Schmeckpeper BJ, Goldman D, Petri M. A promoter polymorphism of tumor necrosis factor alpha associated with systemic lupus erythematosus in african-americans. Arthritis Rheum 1997;40:2207-11.
6. 6 Wu J, Edberg J, Recheda PB, Bansai V, guyre PM, Coleman K, et al. A novel polymorphism of Fc-gammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest 1997;100:1059-70.
7. 7 Theofilopoulos AN. Genetics of systemic autoimmunity. J Autoimmun 1996;9:207-10.
8. 8 Duits AJ, Bootsma H, Derksen RHWM, Spronk PE, Kater L, Kallenberg CGM, et al. Skewed distribution of IgG Rc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum 1995;39:1832-6.
9. 9 Botto M, Theodoridis E, Thompson EM, Beynon HLC, Briggs D, Isenberg DA, et al. FcgammaRIIa polymorphism in systemic lupus erythematosus (SLE): no association with disease. Clin Exp Rheumatol 1996;104:264-8.
10. 10 Smyth LJC, Snowden N, Carthy D, Papasteriades C, Hajeer A, Ollier WER. FcgammaRIIa polymorphism in systemic lupus erythematosus. Ann Rheum Dis 1997;56:744-6.
11. 11 Salmon JE, Millard S, Schachter LA, Arnett FC, Ginzler EM, Gourley MF, et al. FcgammaRIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 1996;97:1348-54.
12. 12 Song YW, Han C, Kang S, Baek H, Lee E, Shin C, et al. Abnormal distribution of Fc-gamma receptor type IIa polymorphisms in Korean patients with systemic lupus erythematosus. Arthritis Rheum 1998;41:421-6.
13. 13 Silva LM, Donadi EA. Is immunogenetic susceptibility to neuropsychiatric systemic lupus erythematosus (SLE) different from non-neuropsychiatric SLE? Ann Rheum Dis 1996;55:544-7.
14. 14 Rousset F, Garcia E, Defrance T, Péronne C, Vezzio N, Hsu D, et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 1992;89:1890-3.
15. 15 Llorente L, Zou W, Levy Y, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, et al. Role of Interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 1995; 181:839-44.
16. 16 Llorente L, Richaud-Patin Y, Fior R, Alcocer-Varela J, Wijdenes J, Morel-Fourrier B, et al. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren's syndrome, and systemic lupus erythematosus. Arthritis Rheum 1994;37:1647-55.
17. 17 Hagiwara E, Gourley MF, Lee S, Klinman DM. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: interferon gamma secreting cells in the peripheral blood. Arthritis Rheum 1996;39:379-85.
18. 18 Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RGJ, Huizinga TWJ. TL-10 secretion, in relation to the haplotypic structure of the human IL-10 locus. Proc Natl Acad Sci USA 1998;95:9465-70.
19. 19 Mehrian R, Quismorio FP, Jr., Strassman G, Stimmler MM, Horwitz DA, Kitridou RC, et al. Synergistic effect between IL-10 and bcl-2 genotypes in determining sysceptibility to systemic lupus erythematosus. Arthritis Rheum 1998;41: 596-602.
20. 20 Eskdale J, Wordsworth P, Bowman S, Field M, Gallagher G. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus. Tissue Antigens 1997;49:635-9.
21. 21 Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphisms in the interleukin-10 gene promoter. Eur J Immunogen 1997;24:1-8.
22. 22 Lazarus M, Hajeer AH, Turner D, Sinnott P, Worthington J, Ollier WER, et al. Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol 1997;24:2314-17.
23. 23 Mok CC, Lanchbury JS, Wai Chan D, Sing Lau C. Interleukin-10 promoter polymorphisms in southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 1998;41:1090-5.
24. 24 Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
25. 25 Verduyn W, Doxiadis UN, Anholts J, Drabbels JJM, Naipal A, D'Amaro J, et al. Biotinylated DRB sequence-specific oligonucleotides. Comparison to serologic HLA-DR typing of organ donors in Eurotransplant. Hum Immunol 1993;37:59-67.
26. 26 Hama N, Boumpas DT. Cerebral lupus erythematosus. Diagnosis and rational drug treatment. CNS Drugs 1995;3:416-26.
27. 27 Van der Linden MW, Westendorp RGJ, Sturk A, Stoeken DJ, Vandenbroucke JP, Breedveld FC, et al. Innate high IL-10 production is associated with susceptibility for systemic lupus erythematosus (SLE). [Abstract]. Arthritis Rheum 1997;40:S307.
28. 28 Llorente L, Richaud-Patin Y, Couderc J, Alarcon-Segovia D, Ruiz-Soto R, Alcocer-Castillejos N, et al. Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus. Arthritis Rheum 1997;40: 1429-35.
29. 29 Keijsers V, Verweij CL, Hazes JMW, Westendorp RGJ, Breedveld FC, Huizinga TWJ. Innate differences in IL-10 production are present at the level of transcription and associated with haplotypes: Association of IL-10 haplotypes and rheumatoid arthritis. Clin Exp Rheumatol 1998; 16:200.
30. 30 Hoffman SA, Shucard DW, Harbeck RJ. The immune system can affect learning: chronic immune complex disease in a rat model. J Neuroimmunol 1998;86:163-80.